Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio
Dongwook Oh,Jung-Soo Pyo,Byoung Kwan Son
Gastroenterology Research and Practice.2018;2018()1
[DOI]
2Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio
Arturs Silovs,Ilze Strumfa,Reinis Riekstins,Zane Simtniece,Andrejs Vanags,Janis Gardovskis
Gastroenterology Research and Practice.2018;2018()1
[DOI]
3Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis
Jihoon Kang,Inhwan Hwang,Changhoon Yoo,Kyu-pyo Kim,Jae Ho Jeong,Heung-Moon Chang,Sang Soo Lee,Do Hyun Park,Tae Jun Song,Dong Wan Seo,Sung Koo Lee,Myung-Hwan Kim,Seung-Mo Hong,Sang Hyun Shin,Dae Wook Hwang,Ki Byung Song,Jae Hoon Lee,Song Cheol Kim,Baek-Yeol Ryoo
Investigational New Drugs.2018;36(4)732
[DOI]
4Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2
Teresa Macarulla,Roberto Pazo-Cid,Carmen Guillén-Ponce,Rafael López,Ruth Vera,Margarita Reboredo,Andrés Muñoz Martin,Fernando Rivera,Roberto Díaz Beveridge,Adelaida La Casta,José Martín Valadés,Joaquina Martínez-Galán,Immaculada Ales,Javier Sastre,Sofia Perea,Manuel Hidalgo
Journal of Clinical Oncology.2019;37(3)230
[DOI]
5Efficacy and safety of nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy in HER2-negative breast cancer
Miaomiao Yang,Huajun Qu,Aina Liu,Jiannan Liu,Ping Sun,Hua Li
Journal of Cancer Research and Therapeutics.2019;15(7)1561
[DOI]
6Currently available first-line drug therapies for treating pancreatic cancer
Jennifer L. Olson,Richard J. Bold
Expert Opinion on Pharmacotherapy.2018;19(17)1927
[DOI]
7Real World First-Line Treatments and Outcomes of Nab-Paclitaxel Plus Gemcitabine, mFOLFIRINOX and GEMOX in Unresectable Pancreatic Cancer from a Chinese Single Institution
Qi Quan,Yixing Wang,Fenghua Wang,Dongsheng Zhang,Xiuxing Chen,Wenzhuo He,Bei Zhang,Guifang Guo
Current Oncology.2020;28(1)209
[DOI]
8Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study
Ana Fernández,Mercedes Salgado,Adelaida García,Elvira Buxò,Ruth Vera,Jorge Adeva,Paula Jiménez-Fonseca,Guillermo Quintero,Cristina Llorca,Mamen Cañabate,Luis Jesús López,Andrés Muñoz,Patricia Ramírez,Paula González,Carlos López,Margarita Reboredo,Elena Gallardo,Manuel Sanchez-Cánovas,Javier Gallego,Carmen Guillén,Nuria Ruiz-Miravet,Víctor Navarro-Pérez,Juan De la Cámara,Inmaculada Alés-Díaz,Roberto Antonio Pazo-Cid,Alberto Carmona-Bayonas
BMC Cancer.2018;18(1)209
[DOI]
9Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine
Gregorio Di Franco,Alice Usai,Niccola Funel,Matteo Palmeri,Ida Elena Rosamaria Montesanti,Matteo Bianchini,Desirée Gianardi,Niccolò Furbetta,Simone Guadagni,Enrico Vasile,Alfredo Falcone,Luca Emanuele Pollina,Vittoria Raffa,Luca Morelli
World Journal of Gastroenterology.2020;26(21)2792
[DOI]
10Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
Hakon Blomstrand,Ursula Scheibling,Charlotte Bratthäll,Henrik Green,Nils O. Elander
BMC Cancer.2019;19(1)2792
[DOI]
11A review on the efficacy and safety of iodine-125 seed implantation in unresectable pancreatic cancers
Sheng-Nan Jia,Fu-Xing Wen,Ting-Ting Gong,Xin Li,Hui-Jie Wang,Ya-Min Sun,Ze-Cheng Yang
International Journal of Radiation Biology.2020;96(3)383
[DOI]
12Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study
Martina Catalano,Giandomenico Roviello,Raffaele Conca,Alberto D’Angelo,Valeria Emma Palmieri,Benedetta Panella,Roberto Petrioli,Anna Ianza,Stefania Nobili,Enrico Mini,Monica Ramello
Current Cancer Drug Targets.2020;20(11)887
[DOI]
13Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review
Fabiana Napolitano,Luigi Formisano,Alessandro Giardino,Roberto Girelli,Alberto Servetto,Antonio Santaniello,Francesca Foschini,Roberta Marciano,Eleonora Mozzillo,Anna Chiara Carratù,Priscilla Cascetta,Pietro De Placido,Sabino De Placido,Roberto Bianco
Cancers.2019;11(7)981
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal